Wengang Ge

1 ta ish

1. Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

   Yongxian Hu, Yali Zhou, Mingming Zhang +25

   MaqolaOAOchiq kirish20222 iqtibos

   ABIABI:AkademIndex/2026.other.082882